Drug target identification of a multi-pass transmembrane G protein coupled receptor antagonist using limited-proteolysis coupled mass spectrometry (LiP-MS)
Harnessing the power of limited proteolysis and ultra-deep mass spectrometry proteomics for small molecule drug target identification and MOA deconvolution